子宫内膜CD138计数对既往胚胎移植失败患者的负向预后价值
该回顾性分析纳入141例内膜日期与组织病理正常、既往两次优质新鲜胚胎移植失败的患者,在自然周期冻胚移植前取内膜行CD138免疫组化。CD138阳性率约31.2%,阳性者临床妊娠率52.7%、种植率46.8%,显著低于阴性者的80.04%和64.9%,且CD138阳性细胞数越多妊娠结局越差。
要点
- 内膜CD138阳性与冻胚移植后临床妊娠率和种植率显著降低相关。
- CD138阳性细胞数越多,妊娠结局越差,提示存在剂量效应关系。
- 取样日经阴道超声发现盆腔游离液体可能是CD138阳性的危险因素。
核心结论
- 子宫内膜CD138阳性细胞计数可能是预测既往两次优质新鲜胚胎移植失败、内膜日期与组织病理正常患者冻胚移植妊娠结局的有价值标志物。
研究设计与样本
- 回顾性分析,纳入141例内膜日期与组织病理特征正常、既往两次优质新鲜胚胎移植失败并在自然周期前接受内膜搔刮的患者。
主要发现
- 141例中约31.2%(44/141)CD138表达阳性,CD138计数范围为0至33。
- 基于CD138阳性细胞密度和计数的ROC曲线下面积分别为0.660和0.658。
- CD138阴性患者临床妊娠率80.04%、胚胎种植率64.9%,均显著高于CD138阳性患者的52.7%和46.8%。
- CD138阳性细胞数越高,妊娠结局越差。
- 内膜取样日经阴道超声发现的盆腔游离液体可能是CD138表达的危险因素。
临床怎么用
- 对既往两次优质新鲜胚胎移植失败且内膜日期与组织病理正常的患者,可考虑检测内膜CD138辅助评估冻胚移植预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the predictive value of endometrial CD138 expression in the natural cycle preceding frozen embryo transfer in patients with normal endometrial dating and histopathologic features, who previously failed the transfer of two high-quality fresh embryos. DESIGN: Retrospective analysis. SETTING: University-affiliated hospital. PATIENT(S): Women with normal endometrial dating and histopathologic features who previously failed the transfer of two high-quality fresh embryos, and who then underwent an endometrial scratching operation preceding a natural cycle. INTERVENTION(S): Paraffin-embedded endometrial samples cut into sections for immunohistochemistry staining of CD138 (syndecan-1) expression, then clinical information for these patients reviewed and analyzed. MAIN OUTCOME MEASURE(S): Clinical rates of pregnancy and implantation. RESULT(S): A total of 141 women met the inclusion criteria. Of these patients, about 31.2% (44 of 141) were positive for CD138 expression, with CD138 counts ranging from 0 to 33. Receiver operating characteristic (ROC) curves were analyzed to determine whether the number of cells expressing CD138 (CD138+ cells) predicted a successful pregnancy. The areas under the ROC curves based on CD138+ cell density and CD138+ cell count were 0.660 and 0.658, respectively. The clinical pregnancy and embryo implantation rates in patients not expressing CD138 (80.04% and 64.9%, respectively) were statistically significantly higher than rates in CD138+ patients (52.7% and 46.8%, respectively). In addition, the higher the number of cells expressing CD138, the worse the outcome of the pregnancy. Finally, clinical data showed that free pelvic fluid on the day of endometrial sampling (identified using transvaginal ultrasound) might be a risk factor for CD138 expression. CONCLUSION(S): Endometrial CD138+ count might be a valuable marker predicting pregnancy outcomes after frozen embryo transfer in patients with normal endometrial dating and histopathologic features who previously failed the transfer of two high-quality fresh embryos.
引用
- Fan X, Li X, Li Y, et al. Endometrial CD138 count appears to be a negative prognostic indicator for patients who have experienced previous embryo transfer failure. Fertil Steril. 2019. PMID: 31843086. doi:10.1016/j.fertnstert.2019.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。